FARE to Take Part in Congressional Briefing on Food Allergy and Public Health
Expert Panel on March 19 to Address Evidence-Based Advances in Food Allergy Prevention and the Importance of Increased Federal Research Funding
McLean, Va.—March 18, 2026—FARE (Food Allergy Research & Education), the nation’s leading charity improving the quality of life and health of those with food allergy through transformative research, education, and advocacy, today announced it will take part in a congressional briefing titled “Food Allergy Research and Public Health,” hosted by the Congressional Food Allergy Research Caucus. The event will take place on Thursday, March 19, from 11:00 a.m. to 12:30 p.m.
The briefing will discuss evidence-based developments in food allergy prevention and treatment, including federally funded research that has changed clinical practice and has the potential to prevent food allergy in hundreds of thousands of children nationwide.
Leading food allergy experts and scientists will discuss the latest research and recent developments in food allergy.
Panelists will include:
Sung Poblete, PhD, RN - CEO of FARE (Food Allergy Research & Education)
Hugh Sampson, MD - Professor of Pediatrics at Icahn School of Medicine at Mount Sinai; Former CoFAR Principal Investigator
Michelle Huffaker, MD - Clinical Assistant Professor of Pulmonary, Allergy & Critical Care Medicine, Stanford University; Director of Clinical and Translational Medicine for the Immune Tolerance Network
R. Sharon Chinthrajah, MD – Professor of Pediatric Food Allergy, Immunology and Asthma, Professor of Medicine and of Pediatrics, Stanford University; CoFAR OUtMATCH Co-Pl, Stanford Site Investigator
The panel will be moderated by Stephen Tilles, MD, clinical professor at the University of Washington Medical Center, who serves as FARE's Research and Strategic Innovation Advisor.
The prevalence of food allergy is rising, affecting more than 33 million Americans, with recent data estimating the societal cost of food allergy in the U.S. to be $370.8 billion per year, with an annual cost of $22,000 per patient. Despite the large and growing food allergy patient community, the level of investment in research from the National Institute of Allergy and Infectious Diseases (NIAID) in the Consortium for Food Allergy Research (CoFAR) has been approximately $12.1 million per year for the past three years.
“We have seen important breakthroughs achieved with existing funding—remarkable returns from federal research investment,” said Dr. Poblete. “Expanding support for food allergy research would reduce the growing economic burden of this disease while accelerating progress toward a cure. There is real momentum in this field, and now is the time for the federal government to strengthen its commitment so we can finally stem the tide of food allergy.”
For more information about FARE, visit us at www.foodallergy.org. To inquire about registration for the event, please email FARE at RSVP@foodallergy.org.
Media Contact:
About FARE (Food Allergy Research & Education)
FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—research, education, and advocacy. FARE's initiatives strive for a future free from food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. To learn more, visit FoodAllergy.org.